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 Although a thorough physical examination and the 
careful use of ancillary testing (CBC, biochemistries, 
diagnostic imaging, etc.) enables the clinician to 
determine what disease process is occurring in a patient, 
determining the actual causative agent can sometimes 
remain elusive despite the clinician’s best efforts.          
In those cases where determining an exact etiology is 
important—usually when an infectious agent is thought 
to be involved— further testing must be employed. This 
testing can be either direct (through the detection          
of antigen through DNA/PCR, histopathology, 
immunohistochemistry, or culture), or indirect (through 
the detection of specific antibodies to an antigen).   
 This antibody detection, known as serology, was 
originally designed to screen flocks to detect the 
presence of a disease. Today it is being used 
increasingly more commonly in individual birds, a 
purpose for which it was never designed. Although         
a valuable diagnostic tool, there are limits to its use 
which sometimes, unfortunately, clinicians do not always 
appreciate and can lead them to make an inappropriate 
diagnosis or institute an inappropriate treatment. 
 This paper seeks to guide clinicians in the use of 
serological tests through reviewing the avian humoral 
immune system, explaining the types of tests available, 
and outlining the different factors that can affect the 
results and their interpretation. 
 
THE AVIAN HUMORAL IMMUNE SYSTEM —  
A QUICK REVIEW 
 The immune system serves two purposes: to clear 
infection from the body, and to develop a pathogen-
specific resistance to protect from future infections.        
It has two layers of defense: 
 
• Nonspecific pathways, responding to all foreign 
material. It includes mechanical barriers (the skin, 
mucosa, etc.) and the innate immune system 
(macrophages, heterophils, thrombocytes and 
complement). It gives the specific immune response 
time to develop; and 
• Specific pathways, including cell-mediated immunity 
(T cells) and humoral immunity (B cells).  
 
 Humoral immunity is the process that is of interest in 
understanding serology. An antigen may activate a        
B-cell directly or initially bind to an accessory cell 
(macrophages, heterophils, and thrombocytes) that 
leads to the activation of T and then B cells. These B 
cells are produced in the bone marrow and mature as B 
lymphocytes in the bursa. They then differentiate into the 
antibody-producing plasma cells.  
 
 These antibodies react with a portion of the 
pathogen’s surface (called the epitope) to maintain 
specificity. They coat extracellular pathogens, allowing 
the immune system to destroy them, while at the same 
time preventing the pathogen from entering target cells. 
(T cells, on the other hand, destroy cells that have 
already being infected or damaged.) 
 This antibody response can be either primary (the first 
time the body has been infected with that pathogen), or 
secondary (occurs with subsequent re-infections).          
A primary response may take 1 to 2 weeks to peak, as 
there is an exponential latent phase with a progressive 
increase in circulating antibody. Levels decline rapidly as 
other antibodies are produced by the immune system.   
A secondary response is much faster; the latent period is 
much shorter, and it usually produces more antibodies 
which last longer.  
 There is a difference between the antibodies 
produced by primary and secondary responses.             
A primary response produces IgM. This is a structurally 
large protein, so large that it is confined to the 
vasculature. After 1 to 2 weeks— and on subsequent  
re-infections—it is replaced by IgG. This is a smaller 
protein, capable of penetrating into tissue spaces.  
 Neonate chicks are not immunocompetent. Initially 
they rely on maternal immunity passed through the yolk 
and the albumen of the egg. The chick’s immune system 
begins to function at around 2 weeks of age and 
maternal antibodies will be absent by 30 to 42 days. 
Most chicks begin to produce antibody at adult levels at 
around 6 weeks of age. 
 
SEROLOGICAL TESTS 
 A variety of serological tests are available today. The 
selection of the best test requires a clinician to have an 
understanding of the principles of immunology and the 
interaction between host and pathogen. He/she also 
needs to have an understanding of the types of tests 
available and the advantages and disadvantages of 
each (see Table 1). 
 
UNDERSTANDING THE USES AND LIMITATIONS 
OF SEROLOGY  
 Serology has several advantages that make it unlikely 
its use will ever disappear. First, PCR and other 
antigen-detection tests can sometimes be too accurate, 
detecting extremely low levels of antigen (or portions of 
antigen) that may not be significant. At other times the 
antigen may be extremely difficult to detect; it may shed 
only intermittently, or at very low concentrations. In both 
these cases, serological evaluation of the bird (or birds) 
may better detect the presence of significant levels of 
antigen. Serological assays of a flock may be more 
sensitive in detecting a pathogen than more direct 
antigen-detection tests. 
 A second advantage is its relatively low invasiness. 
Direct testing for an antigen that is only intermittently 
shed (if at all) often requires the collection of a tissue 
sample, either by autopsy or biopsy. Serology, on the 
other hand, simply requires a blood sample.  
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 Although at first glance these appear to be almost 
overwhelming advantages, other factors play key roles in  
the selection of an appropriate serological test. These 
factors can be categorised into three groups: 
 
The Characteristics of the Test 
 The selection of the test is of paramount importance. 
Is this test appropriate for this species? Has it been 
thoroughly validated for this disease?  Antibodies are not 
necessarily consistent across species; a test that works 
well in poultry may not work well, or at all, in psittacines. 
 The sensitivity and specificity of a test will often 
determine its usefulness. Sensitivity is a measure of a 
test’s ability to accurately detect antibodies in an infected 
bird. A highly sensitive test will hopefully detect most of 
the antibody-positive birds in a population. As such, it is 
useful as a screening test during the early days of a 
disease outbreak, where it is important to quickly identify 
potentially infected birds. Once these birds have been 
removed from a population, it becomes more important 
to be sure that the remaining birds that have tested 
negative are, in fact, not infected.  At this time a highly 
specific test is desirable. Specificity is the proportion of 
truly noninfected birds that test negative. A clinician 
using a serological test should therefore be aware of the 
published sensitivity and specificity of a test. 
 Another test characteristic to be considered is its 
complexity to perform. The more complex a test is, the 
more susceptible it is to operator error, leading to 
erroneous results. Errors can occur in the collection, 
storing, and transport of the sample to the lab, and then 
again in carrying out the test. Equipment can be faulty, 
the operator may be inexperienced, or reagents may be 
out of date. There may also be error in the interpretation 
of the results, or even dissension about the significance 
of the results. 
 In some cases a test requires specific reagents 
which may not be readily available (e.g., the 
hemagglutination inhibition test for PBFD requires 
specially prepared galah erythrocytes, which are readily 
available in Australia, but harder to obtain elsewhere. 
[NB: goose erythrocytes can sometimes be used.])    
This limits its usefulness in the USA, UK, and Europe. 
 
The Characteristics of the Antigen and the Disease 
 Some antigens/diseases are not readily detectable by 
some tests due to the behavior of that antigen. Some 
viruses, for example, do not agglutinate erythrocytes, 
making hemagglutination inhibition tests unsuitable. 
 Some pathogens, such as viruses like the influenza A 
virus, undergo antigenic variance wherein the surface 
proteins of the virus change and prevent immediate 
detection. Other pathogens, such as Mycobacterium and 
Aspergillus, seem to not provoke an antibody response 
in some patients for, as yet, undetermined reasons.      
In these situations, false-negative test results may occur.  
 From an epidemiological point of view, there will 
always be false-positive and false-negative results for 
any test. The clinician must therefore interpret results 
with care; if a disease is of a low incidence in a species 
or in a geographical area, is a positive result truly 
 
significant or even accurate?  And vice versa? As with 
any laboratory test, the results must be interpreted as a 
part of the diagnostic test, not as a sole entity. 
 
Host Factors 
 Some clinicians seem to fall into the trap of forgetting 
that there is a patient attached to a laboratory test result. 
How the host is responding to the challenge of a 
pathogen has a major impact on the interpretation of a 
serological test (or any other test). The interaction 
between the host and the pathogen must be understood 
by the clinician in order to accurately assess the 
patient’s status. 
 In the initial stages of infection (the pre-patent period) 
there will be a delay while the immune system first 
recognizes the presence of an antigen and then mounts 
a response to it (usually in the form of IgM). In this pre-
patent period (usually 1–2 weeks), a serological assay 
that only detects IgG will give a false-negative result.   
On the other hand, direct antigen-detection tests may 
have a pre-patent period of only 1–2 days, and are 
therefore more reliable in detecting early infection. 
 With appropriate treatment or an effective immune 
defence (or both) the host will inactivate/kill the pathogen 
and then clear it from the body. During this process there 
is a rising antibody titer. After the pathogen has been 
cleared, these titres should start to decline. The rate of 
this decline is dependent on many factors: the strength 
of the immune system, the persistence of the antigen, 
and the degree of response to a specific pathogen.        
A single-point serological assay is unable to distinguish 
between rising and declining antibody titres; serial tests, 
2–3 weeks apart, are needed to assess what is 
happening in the patient. For example, polyomavirus 
infection in a bird may result in detectable antibody titers 
for the life of the bird, even though the bird cleared the 
virus from its body after a few weeks or months.           
So while a single serological test may indirectly detect 
that a pathogen was/is present in the patient, it cannot 
(by itself) detect the ongoing presence of disease.  
 The serological detection of pathogens that are 
ubiquitous in the environment is fraught with error.  Most 
birds, for example, are exposed to Aspergillus spp at 
some time or another; relatively few develop 
aspergillosis. The detection of antibodies to Aspergillus 
does not, therefore, constitute a diagnosis of 
aspergillosis; rather, it indicates the patient has been 
exposed to the pathogen and has mounted an immune 
response to it.   
 Despite the presence of a pathogen actively causing 
disease, some birds fail to produce antibodies. This 
immunosuppression can be due to a number of factors. 
Including concurrent disease, which frequently causes 
immunosuppression. Viruses such as PBFD, 
polyomavirus, pox, and herpes; bacterial or parasitic 
infections; and aflatoxicosis have all been implicated in 
immunosuppressed patients. Certain drugs, such as 
tetracycline, tylosin, and gentamicin, are known to 
decrease antibody production. Environmental stress, 
including inadequate temperatures, humidity, noise, and 
poor nutrition, is known to suppress both the bursa and 
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the thymus, possibly through corticosteroid production 
by the adrenal gland. Immunosuppressed birds, for 
whatever reason, may give a false-negative result. 
 A final consideration is that antibodies produced in 
response to a particular pathogen may be difficult to 
distinguish from antibodies produced against another 
pathogen. Antibodies produced by vaccination may be 
indistinguishable from those produced by natural 
infection. In either case, false-positive results can be 
produced.  
 
THE USE OF SEROLOGY  
Disease Outbreaks 
 Serology is often employed in the face of an outbreak 
of an infectious disease. Serology has the advantages of 
being relatively simple (most labs can perform it), quick, 
and cost-effective, particularly when compared with 
other (more direct) tests such as DNA/PCR and 
histopathology. Large numbers of birds can be tested 
quickly, giving an indication of the incidence of the 
disease in a given population. In the early stages of an 
outbreak, high sensitivity is needed; all infected (positive 
result) birds need to be identified as soon as possible. 
Sensitivity can be increased by using known high 
sensitivity tests; by increasing the sample size of the 
population being tested; and by parallel testing, using 
several different tests to increase the likelihood of an 
infected bird being detected.  
 Once the incidence of a disease has been 
determined, steps can be taken to control it. This will 
usually require the removal of birds that have tested 
positive and further testing of those that have tested 
negative. This introduces the problem of false-negative 
results― seronegative birds that are latent carriers of a 
disease. At this time highly specific tests are needed, 
and may require the employment of a different 
serological test or tests. As the incidence of a disease 
approaches zero, the detection of these latent carriers 
becomes even more difficult, and complete eradication 
may not be possible without complete culling. 
 
Specific-Pathogen Free (SPF) Flocks 
 One of the cornerstones of successful farming is 
maintaining a disease-free flock. This is no different with 
birds, whether it is an intensive poultry flock, a zoological 
collection, or an avicultural facility. The development of a 
SPF flock requires the testing of all members of that 
flock, preferably before they join it. 
 Vets advising clients on a SPF protocol encounter 
similar problems to those faced by vets dealing with an 
outbreak of disease. No test can hope to be 100% 
sensitive and 100% specific. Therefore parallel testing 
(several different tests, not necessarily all serological) 
and serial testing (repeated testing over a period of time) 
may help to detect those birds that are latent carriers 
and test negative the first time. While this can add 
considerably to the cost of new birds, this must be 
 
weighed against the costs of remedying an outbreak of 
disease if it escapes detection and is introduced.  
 
The Individual Bird 
 While serological tests are extremely useful in 
screening flocks, they often lack the sensitivity and 
specificity required for screening an individual bird. While 
relatively inexpensive, they often lack the accuracy of a 
more direct antigen-detection test. However, these more 
direct tests only detect the presence of a pathogen, not 
necessarily the presence of a disease. 
 Combining the two tests together can lead to a better 
screening of an individual. By looking for the pathogen, 
and the body’s immune response to it, a better 
understanding of the bird’s status can be achieved. 
When combined with ancillary tests such as hematology 
and biochemistry (which can reflect the effect the 
pathogen is having on the bird) a more complete picture 
of the host–pathogen interaction becomes apparent. 
 
CONCLUSION 
 Serology— the detection of an antibody response to a 
pathogen— is commonly employed in avian medicine. 
Any clinician contemplating its use must have a good 
understanding of the principles of its use, particularly its 
shortcomings. But, when used in conjunction with 
antigen detection tests and other tests to assess the 
bird’s response to disease, it provides a valuable tool in 
the detection and assessment of disease.  
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Table 1.   Serological Tests 
 
 
Test Technique Disease/Pathogen Advantages Disadvantages 
 
ELISA 
 
Detection of 
antibody–antigen 
complex by use 
of a second 
enzyme-
conjugated 
antibody that 
produces a color 
change 
 
Adenovirus in 
poultry 
 
Mycobacterium 
 
Chlamydophila 
 
Paramyxoviruses 
 
Aspergillus 
 
 
Simple to 
operate – 
rapid, 
automated 
 
Requires species-
specific second 
antibody 
 
Hemagglutination 
Inhibition 
 
Proteins present 
on the surface of 
some viruses 
cause 
agglutination of 
erythrocytes. By 
adding 
antibodies 
against these 
viral proteins, this 
agglutination is 
inhibited. 
Therefore if 
agglutination 
occurs, no virus-
specific 
antibodies are 
present, and vice 
versa. Titers are 
determined by 
serial dilution of 
the sample. 
 
 
Circovirus 
 
Paramyxoviruses 
 
Eastern Equine 
Encephalitis 
 
Avian Influenza 
 
Secondary 
antibodies not 
required 
 
Inexpensive 
 
Good 
sensitivity 
 
Serum must be treated 
to clear non-specific 
agglutination 
 
Not all avian viruses 
cause agglutination 
 
Complement 
Fixation 
 
Complement is 
needed to bind 
antibody and 
antigen. 
Detection of 
complement 
fixation 
demonstrates the 
presence of the 
antigen. 
 
 
Polyomavirus 
 
Psittacine 
Herpesvirus 
 
Mycobacterium 
 
Aspergillus 
 
Chlamydophila 
 
Quick, simple  
test 
 
Moderate 
sensitivity and 
specificity 
 
Can have false positives 
 
Doesn’t work in all 
species 
 
Usually only detects IgM 
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Table 1.  (continued) 
 
 
 
 
Virus 
Neutralization 
 
Serum is mixed 
with an antigen. If 
antigen-specific 
antibody is 
present in the 
serum, the antigen 
will be neutralized, 
and will be 
incapable of 
causing cytopathic 
changes in a cell 
culture. 
 
 
Polyomavirus 
 
Psittacine 
Herpesvirus 
 
Very specific 
and sensitive 
 
Detects both 
IgM & IgG 
 
Takes up to 7 days to 
run – requires both cell 
culture and virus 
propagation 
 
Nonspecific substances 
in the serum can give a 
positive result 
 
Immunodiffusion 
assay 
 
Antibody and 
antigen placed in 
agar gel diffuse 
towards each 
other. If an 
antibody-antigen 
complex forms, a 
precipitate 
develops that is 
visible as a white 
line. 
 
 
Adenovirus in 
poultry 
 
Reovirus in 
psittacines 
 
Simple and 
cheap 
 
Secondary 
antibodies not 
required 
 
Moderate 
specificity 
 
Low sensitivity 
 
Difficult to quantify 
 
Immuno-
Fluorescent 
Antibody 
 
Multiple dilutions 
of serum are 
incubated with 
cells infected with 
Ag fixed to plastic. 
A fluorescent-
labeled second 
antibody is added. 
Positive results 
can be viewed 
with a fluorescent 
microscope 
 
 
Avian Influenza 
 
Chlamydophila 
 
Quick and 
simple 
 
Moderate 
sensitivity and 
specificity 
 
Requires species 
specific second 
antibody 
 
Requires fluorescence 
microscope 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
